Bacterial protein structure could contribute to targeted anticancer drug delivery
A recently identified bacterial protein, named BeeR, is contributing to the design of novel anticancer drug delivery systems.
Researchers from King’s College London (UK) and the University of Washington (WA, USA) have discovered a previously unknown actin-like protein in a family of bacteria found in microbiomes of the human gut and soil. This protein’s unique structure has the potential to aid drug delivery of cancer treatments to the sites of tumors.